Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TET1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CYP4F3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MXRA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM26F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35G3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HELZ2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCBP1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AVPI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HPS6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUPT6H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHGA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LGALS8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD274 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf66 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on